Accelerates growth in cell analysis, new technology and market development PEARLAND, Texas–Base Pair Biotechnologies, Inc., The Aptamer Discovery Company™, today announced the completion of its $3.2 Million Series A-3 financing round and the opening of its new 5,000 square foot laboratory and office facility in Pearland, TX, a Houston suburb. Toronto-based Eventi Capital Partners Inc. […]
SAN DIEGO, CA — NanoCellect Biomedical Inc., a developer of microfluidic cell sorting technologies for cell based assays, today announced the completion of a $10 million Series B financing round, including convertible notes. The financing included the participation of new investors Illumina Ventures, Anzu Partners, Vertical Venture Partners, and 5 Prime Ventures. Also participating in […]
Sphere Fluidics, a company providing single cell analysis systems underpinned by its patented picodroplet technology, and Geneva Biotech, an EMBL spin-out developing world-class viral and non-viral DNA delivery systems, have received a €1.6 million grant from Eurostars. The funding will be used to develop large DNA cargo gene delivery and genome engineering systems. The Eurostars funding programme […]
LEXINGTON, Mass.—-Quanterix Corporation, a company with a next generation, ultra-sensitive digital platform that advances precision health, today announced the commencement of the initial public offering of shares of its common stock pursuant to a registration statement on Form S-1 filed with the Securities and Exchange Commission (the “Commission”). The offering consists of 3,340,000 shares of common stock […]
€1.6 million grant will support ‘precise docking of very large DNA cargoes in genomes’ project Cambridge, UK, and Geneva, Switzerland: Sphere Fluidics, a company providing single cell analysis systems underpinned by its patented picodroplet technology, and Geneva Biotech, an EMBL spin-out developing world-class viral and non-viral DNA delivery systems, have received a €1.6 million grant from Eurostars. The […]
Symcel secures €3.6 million Horizon 2020 Phase II grant for clinical validation of customized antimicrobial susceptibility testing Multi-resistant bacterial sepsis infections to be validated utilising Symcel’s sensitive screening technology Symcel, the company behind the revolutionary cell-based assay tool for real-time cell metabolism measurements, calScreener™, has secured €3.572 million Horizon 2020 funding to support the company’s evaluation […]
Cambridge, UK Base4 Innovation Ltd, the biotechnology company specialising in single molecule DNA sequencing, closed an oversubscribed funding round last month, led by Longwall Ventures. The funding round, capped at £5 million, is the Company’s largest to date, with a total of £21.3 million raised since 2009. The funds will be used to expand the […]
The European Commission has appointed Phase Holographic Imaging, Bundesanstalt für Material-forschung und Prüfung (Germany’s federal technology research institute), Malmö, Umeå, Copenhagen and Turku University to develop improved methods for clinically diagnosing cancer. The €2.1 million grant finances a three-year research project which is coordinated by Malmö University and commercialized by Phase Holographic Imaging (PHI). Current methods for […]
New Cambridge spin-out company commercialises disruptive technology that enables rapid generation of pure and consistent batches of human cell types Exclusive IP licensed from the University of Cambridge Geographically diversified, top-tier investor team includes key industry leaders to support early company development Cambridge, UK: Elpis BioMed, a University of Cambridge spin-out, applying its disruptive and proprietary “direct cell […]
IsoPlexis will use four new NIH grants to advance research and development of immunotherapies to treat solid tumors, bone marrow disease, autoimmune diseases and infectious diseases. Branford, Conn.—IsoPlexis Corporation (IsoPlexis), a privately held life sciences company at the forefront of single-cell analytics technology and the immune-based cancer treatment revolution, announced today that it has received […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
